Zydus has developed an innovative Semaglutide Injection (15 mg/3 ml) in a prefilled cartridge administered using a patient-friendly reusable pen for which the company has exclusive rights
This deal marks a major step for Alteogen as it pushes its Hybrozyme platform deeper into the oncology market
The partnership initially will focus on cardiovascular and kidney diseases
LOTTE Biologics will provide advanced manufacturing services for monoclonal antibody intermediates and their conjugates
The supplements are made using only vegetarian-sourced ingredients
Kelun-Biotech and Crescent Biopharma forged a collaboration covering SKB105/CR-003 and SKB118, a PD-1 x VEGF bispecific antibody also known as CR-001
The therapy targets the LRRC15 protein and is designed for enhanced tumor penetration and differentiated anti-tumor activity in solid tumors with the highest unmet needs.
The trial will evaluate the efficacy and safety of IPX203 versus immediate-release levodopa/carbidopa
The MUSE system offers a minimally invasive solution for treating gastroesophageal reflux disease
The trial will evaluate safety endpoints including dose-limiting toxicities and adverse events
Subscribe To Our Newsletter & Stay Updated
